According to the report, the Asia Pacific Digital Breast Tomosynthesis (DBT) Equipment Market size is valued at USD 233.93 million in 2019 and is expected to grow at a CAGR of 14.8% to reach USD 466.44 million by 2024 from 2019 to 2024. It captures 20% of the global market.
DBT is a 3D breast imaging technique. It operates on full-field digital mammography technology. It has a rotating X-ray tube that projects multiple images from different angles at a low radiation dose through the compressed breast. A special monitor is utilized for image viewing.
The better alternative for 2D mammography resulting in higher adoption rate, savory government policies, Upgradation of existing capital and purchases of new equipment, high risk of breast cancer, unhealthy lifestyle, rampant urbanization, and augmenting population are the primary drivers of market growth.
Asia Pacific Digital Breast Tomosynthesis (DBT) Equipment Market has been segmented and sub-segmented into the following categories
On the basis of Hospitals captured larges market share. Its growth rate is projected to be nearly 15% for the forecast period.
On the basis of region, the Asia Pacific is the fastest-growing market currently and will retain this position till the end of the aforementioned forecast period. China accounted for the largest market share in this market.
Top Companies leading the Asia Pacific Digital Breast Tomosynthesis (Dbt) Equipment Market Profiled in the Report are Hologic Inc., Siemens Healthineers, Fujifilm Corporation. Other players in the market include GE Healthcare, Internazionale Medico Scientifica S.r.l. and Planmed Oy.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 DBT Equipment
5.1.3 3-D Upgradation
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 End User
5.2.1 Introduction
5.2.2 Hospitals
5.2.3 Diagnostic Centres
5.2.4 Y-o-Y Growth Analysis, By End User
5.2.5 Market Attractiveness Analysis, By End User
5.2.6 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
6.7 Rest of APAC
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Hologic Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Siemens Healthineers
8.3 Fujifilm Corporation
8.4 GE Healthcare
8.5 Internazionale Medico Scientifica S.r.l.
8.6 Planmed OY
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
